全文获取类型
收费全文 | 310763篇 |
免费 | 27316篇 |
国内免费 | 13649篇 |
专业分类
耳鼻咽喉 | 2752篇 |
儿科学 | 6717篇 |
妇产科学 | 5237篇 |
基础医学 | 48941篇 |
口腔科学 | 6246篇 |
临床医学 | 24627篇 |
内科学 | 48159篇 |
皮肤病学 | 4388篇 |
神经病学 | 28422篇 |
特种医学 | 6705篇 |
外国民族医学 | 99篇 |
外科学 | 22520篇 |
综合类 | 46718篇 |
现状与发展 | 51篇 |
一般理论 | 7篇 |
预防医学 | 14529篇 |
眼科学 | 5114篇 |
药学 | 40065篇 |
62篇 | |
中国医学 | 11314篇 |
肿瘤学 | 29055篇 |
出版年
2024年 | 265篇 |
2023年 | 4838篇 |
2022年 | 6673篇 |
2021年 | 12653篇 |
2020年 | 11006篇 |
2019年 | 9663篇 |
2018年 | 9355篇 |
2017年 | 9792篇 |
2016年 | 10071篇 |
2015年 | 11374篇 |
2014年 | 17904篇 |
2013年 | 21079篇 |
2012年 | 17813篇 |
2011年 | 20946篇 |
2010年 | 17352篇 |
2009年 | 17576篇 |
2008年 | 17672篇 |
2007年 | 17189篇 |
2006年 | 15603篇 |
2005年 | 14027篇 |
2004年 | 11943篇 |
2003年 | 10577篇 |
2002年 | 8702篇 |
2001年 | 7448篇 |
2000年 | 6265篇 |
1999年 | 5247篇 |
1998年 | 4273篇 |
1997年 | 3907篇 |
1996年 | 3290篇 |
1995年 | 3319篇 |
1994年 | 2948篇 |
1993年 | 2435篇 |
1992年 | 2109篇 |
1991年 | 1899篇 |
1990年 | 1644篇 |
1989年 | 1356篇 |
1988年 | 1175篇 |
1987年 | 1018篇 |
1986年 | 920篇 |
1985年 | 1431篇 |
1984年 | 1297篇 |
1983年 | 914篇 |
1982年 | 978篇 |
1981年 | 783篇 |
1980年 | 667篇 |
1979年 | 550篇 |
1978年 | 396篇 |
1977年 | 326篇 |
1976年 | 314篇 |
1975年 | 202篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
《Vaccine》2022,40(32):4296-4300
Advanced computational methodologies suggested SARS-CoV-2, nonstructural proteins ORF1AB, ORF3a, as the source of immunodominant peptides for T cell presentation. T cell immunity is long-lasting and compatible with COVID-19 pathology. Based on the supporting clinical data, nonstructural SARS-CoV-2 protein vaccines could provide global immunity against COVID-19. 相似文献
32.
《Clinical microbiology and infection》2022,28(8):1152.e1-1152.e6
ObjectivesDespite the possibility of concurrent infection with COVID-19 and malaria, little is known about the clinical course of coinfected patients. We analysed the clinical outcomes of patients with concurrent COVID-19 and malaria infection.MethodsWe conducted a retrospective cohort study that assessed prospectively collected data of all patients who were admitted between May and December 2020 to the Universal COVID-19 treatment center (UCTC), Khartoum, Sudan. UCTC compiled demographic, clinical, laboratory (including testing for malaria), and outcome data in all patients with confirmed COVID-19 hospitalized at that clinic. The primary outcome was all-cause mortality during the hospital stay. We built proportional hazard Cox models with malaria status as the main exposure and stepwise adjustment for age, sex, cardiovascular comorbidities, diabetes, and hypertension.ResultsWe included 591 patients with confirmed COVID-19 diagnosis who were also tested for malaria. Mean (SD) age was 58 (16.2) years, 446/591 (75.5%) were males. Malaria was diagnosed in 270/591 (45.7%) patients. Most malaria patients were infected by Plasmodium falciparum (140/270; 51.9%), while 121/270 (44.8%) were coinfected with Plasmodium falciparum and Plasmodium vivax. Median follow-up was 29 days. Crude mortality rates were 10.71 and 5.87 per 1000 person-days for patients with and without concurrent malaria, respectively. In the fully adjusted Cox model, patients with concurrent malaria and COVID-19 had a greater mortality risk (hazard ratio 1.43, 95% confidence interval 1.21-1.69).DiscussionCoinfection with COVID-19 and malaria is associated with increased all-cause in-hospital mortality compared to monoinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 相似文献
33.
We present the case of a male patient with severe SARS-CoV-2 pneumonia, with simultaneous onset of p-ANCA positive rapidly progressive glomerulonephritis. We discuss the different therapeutic possibilities, emphasising the appropriateness of their administration according to the time in the course of the infection. 相似文献
34.
35.
36.
37.
We have been experiencing multiple waves of the coronavirus disease 2019 (COVID-19) pandemic. With these unprecedented waves, we have entered into an era of ‘new normal’. This pandemic has enforced us to rethink the very basics of childhood learning: Habits, health etiquette, and hygiene. Rehabilitation has immense importance during this pandemic considering a few aspects. Multidis ciplinary COVID-19 rehabilitation clinics are essential to address the demand. The equitable distribution of COVID-19 rehabilitation services for differently-abled individuals during the pandemic is an important aspect. Rehabilitation needs identification and further studies on various rehabilitation interventions are among the key unmet future research needs. 相似文献
38.
《Journal of vascular and interventional radiology : JVIR》2022,33(10):1213-1221.e5
PurposeTo investigate the pharmacokinetics (PK) and early effects of conventional transarterial chemoembolization (TACE) using sorafenib and doxorubicin on tumor necrosis, hypoxia markers, and angiogenesis in a rabbit VX2 liver tumor model.Materials and MethodsVX2 tumor-laden New Zealand White rabbits (N = 16) were divided into 2 groups: 1 group was treated with hepatic arterial administration of ethiodized oil and doxorubicin emulsion (DOX-TACE), and the other group was treated with ethiodized oil, sorafenib, and doxorubicin emulsion (SORA-DOX-TACE). Animals were killed within 3 days of the procedure. Levels of sorafenib and doxorubicin were measured in blood, tumor, and adjacent liver using mass spectrometry. Tumor necrosis was determined by histopathological examination. Intratumoral hypoxia-inducible factor (HIF) 1α, vascular endothelial growth factor (VEGF), and microvessel density (MVD) were determined by immunohistochemistry.ResultsThe median intratumoral concentration of sorafenib in the SORA-DOX-TACE group was 17.7 μg/mL (interquartile range [IQR], 7.42–33.5 μg/mL), and its maximal plasma concentration (Cmax) was 0.164 μg/mL (IQR, 0.0798–0.528 μg/mL). The intratumoral concentration and Cmax of doxorubicin were similar between the groups: 4.08 μg/mL (IQR, 3.18–4.79 μg/mL) and 0.677 μg/mL (IQR, 0.315–1.23 μg/mL), respectively, in the DOX-TACE group and 1.68 μg/mL (IQR, 0.795–4.08 μg/mL) and 0.298 μg/mL (IQR, 0.241–0.64 μg/mL), respectively, in the SORA-DOX-TACE group. HIF-1α expression was increased in the SORA-DOX-TACE group than in the DOX-TACE group. Tumor volume, tumor necrosis, VEGF expression, and MVD were similar between the 2 groups.ConclusionsThe addition of sorafenib to DOX-TACE delivered to VX2 liver tumors resulted in high intratumoral and low systemic concentrations of sorafenib without altering the PK of doxorubicin. 相似文献
39.
目的 基于网络药理学探讨并分析筒鞘蛇菰(Balanophora involucrata Hook. f.,BIH)治疗肝损伤的作用及分子机制,并通过大鼠体内实验验证相关预测靶点及筒鞘蛇菰提取物-蛇菰多糖(Polysaccharides of Balanophora involucrata Hook. f.,BPS)对实验性肝损伤的保护作用。方法 化学专业数据库、TCMID和TCMSP平台检索筒鞘蛇菰组成的化合物及可能靶点,以肝损伤为关键词检索GeneCards和网站,获得相关靶点,绘制Venn图,选交集靶点,将“化合物-靶点和疾病-靶点”关系导入Cytoscape V3.7.2软件,获得化合物-靶点-疾病的三重网络,对化合物及相关靶点蛋白行分子对接,并用交集靶点绘制蛋白互作网络图及进行GO生物功能和KEGG信号途径富集分析。结果 筒鞘蛇菰主要成分有11个化合物,其中与肝损伤有37个交集靶点,高度关联靶点包括NOS3、ESR1、TNF、MAOA、PTGS2、IL10等,GO和KEGG富集分析发现筒鞘蛇菰治疗肝损伤的分子机制,可能与调节肾上腺素能信号通路、cGMP-PKG信号及神经活性配体-受体交互通路等有关,而且ADRA1B、ADRA2A、ADRA2C、ADRB1/2等基因高度富集于这些通路中。动物体内实验发现BPS灌胃处理可减轻肝组织损伤、调控血清炎症因子肿瘤坏死因子α(Tumor necrosis factor, TNF-α)和白细胞介素10(IL-10)水平、提高抗氧化酶超氧化物歧化酶(superoxide dismutase,SOD)活性,并增强肝组织内氧化应激相关蛋白核因子E2相关因子2(NF-E2-related factor 2,NRF2)和醌NADH脱氢酶1(NQO1)的表达,从而抑制大鼠体内氧化应激损伤、减轻炎症反应和细胞凋亡,达到保护实验性肝损伤的作用。结论 本研究初步确定筒鞘蛇菰治疗肝损伤的有效成分、“化合物-蛋白-靶点”关联网络及发挥作用的分子机制,并通过动物体内实验证实蛇菰多糖保护肝损伤的机制与上调NRF2/NQO1通路来减轻氧化应激反应性损伤、减轻肝细胞凋亡有关。 相似文献
40.
目的:探讨消化道肿瘤中同源重组修复相关基因(homologous recombination repair related gene,HRR)突变的发生情况及临床意义。方法:共92例消化道肿瘤患者,79例患者进行了血液标本HRR检测,53例患者进行了组织标本HRR检测,40例患者同时行血液和组织的HRR基因检测,收集患者基因检测结果及临床相关资料。结果:在79例患者血液标本检测中发现10例(12.6%)有临床意义HRR突变,在53例患者组织标本检测中发现9例(17.0%)有临床意义HRR突变。40例同时行血液和组织的HRR基因检测患者中常见的有临床意义HRR突变为CDK12突变4例(10.0%)、ATM突变3例(7.5%)、BRCA1突变2例(5.0%)。13例有临床意义HRR突变患者中常见共存突变为TP53突变10例(76.9%)、APC突变5例(38.5%)、PIK3CA突变4例(30.8%)。40例患者中13例患者血液和/或组织中有临床意义HRR突变,27例患者血液和组织中均无任何临床意义HRR突变且两组相比,有临床意义HRR突变组肿瘤突变负荷(tumor mutational burden,TMB)为6.17(2.24~11.52),而未携带HRR突变组TMB为0.4(0~3.75),差异有统计学意义(P<0.05)。40例患者组织检测中7例HRR有临床意义的突变,33例无HRR突变,血液检测中10例HRR有临床意义的突变,30例无HRR突变,一致性检验的Kappa值为0.333(P=0.031)。结论:携带有临床意义HRR突变的消化道肿瘤患者TMB更高,血液和组织检测HRR突变有较好的一致性。 相似文献